Published in Biochim Biophys Acta on February 04, 1999
MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes. J Biol Chem (2009) 1.30
Mitochondrial uncouplers with an extraordinary dynamic range. Biochem J (2007) 1.16
AMP decreases the efficiency of skeletal-muscle mitochondria. Biochem J (2000) 1.00
Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport. Exp Neurol (2003) 0.87
TGF-beta1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors. BMC Neurosci (2004) 0.84
Acute knockdown of uncoupling protein-2 increases uncoupling via the adenine nucleotide transporter and decreases oxidative stress in diabetic kidneys. PLoS One (2012) 0.82
Alterations in voltage-sensing of the mitochondrial permeability transition pore in ANT1-deficient cells. Sci Rep (2016) 0.80
Transcription factor NF-kappa B represses ANT1 transcription and leads to mitochondrial dysfunctions. Sci Rep (2017) 0.75
The mitochondrial BKCa channel cardiac interactome reveals BKCa association with the mitochondrial import receptor subunit Tom22, and the adenine nucleotide translocator. Mitochondrion (2016) 0.75
Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases. Eur Heart J (2000) 2.52
Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation (1999) 2.03
High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation (2005) 1.84
[Prospective study of the incidence, pathogenesis and therapy of spontaneous, by coronary angiography diagnosed coronary artery dissection]. Z Kardiol (1998) 1.77
Biglycan is required for adaptive remodeling after myocardial infarction. Circulation (2008) 1.72
Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol (1997) 1.65
Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers. Gene Ther (1999) 1.62
Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest (2001) 1.49
[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection]. Dtsch Med Wochenschr (1995) 1.46
[New concepts in the diagnosis of inflammatory myocardial disease]. Dtsch Med Wochenschr (1997) 1.41
Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med (1997) 1.32
Tissue-specific transcription pattern of the adenine nucleotide translocase isoforms in humans. FEBS Lett (1997) 1.31
Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus. Diabetologia (2006) 1.29
The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis. Clin Exp Immunol (1983) 1.26
Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart (1996) 1.23
Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy. J Med Virol (2008) 1.18
PTCA: periprocedural platelet activation. Part II of the Duesseldorf PTCA platelet study (DPPS) Eur Heart J (1996) 1.12
Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets. J Mol Med (Berl) (2006) 1.12
Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation (1999) 1.12
Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation (1999) 1.11
Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol (1985) 1.08
Laminin distribution and autoantibodies to laminin in dilated cardiomyopathy and myocarditis. Am Heart J (1989) 1.05
Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry. Clin Res Cardiol (2014) 1.04
Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol (2000) 1.04
Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. Circulation (1990) 1.02
Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation (1999) 1.02
Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Gene Ther (2000) 0.97
Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation (1993) 0.97
Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res (1989) 0.94
Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J (1994) 0.94
Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J Hypertens (2000) 0.94
The possible role of myocardial biopsy in systemic sclerosis. Rheumatology (Oxford) (2000) 0.92
Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis. J Mol Cell Cardiol (2012) 0.91
Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing. J Am Coll Cardiol (2000) 0.91
Late prosthetic valve endocarditis. Eur Heart J (1995) 0.91
Immunochemical characterization of the adenine nucleotide translocator. Organ specificity and conformation specificity. Eur J Biochem (1984) 0.90
The antigenic characteristics and the significance of the adenine nucleotide translocator as a major autoantigen to antimitochondrial antibodies in dilated cardiomyopathy. Adv Myocardiol (1985) 0.89
Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol (1994) 0.89
Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro. J Thromb Haemost (2009) 0.89
Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. Cardiovasc Res (1998) 0.88
Treatment of chronic myocarditis with corticosteroids. Eur Heart J (1995) 0.88
Adenovirus-based phospholamban antisense expression as a novel approach to improve cardiac contractile dysfunction: comparison of a constitutive viral versus an endothelin-1-responsive cardiac promoter. Circulation (2000) 0.88
Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. Virology (1994) 0.87
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). Am J Cardiol (2000) 0.87
Disturbance of myocardial energy metabolism in experimental virus myocarditis by antibodies against the adenine nucleotide translocator. Cardiovasc Res (1999) 0.87
The role of sensitized T-cells in myocarditis and dilated cardiomyopathy. Int J Cardiol (1996) 0.87
The ADP/ATP carrier as a mitochondrial auto-antigen--facts and perspectives. Ann N Y Acad Sci (1986) 0.86
[Detection of enteroviral RNA in endomyocardial biopsies in inflammatory cardiomyopathy and idiopathic dilated cardiomyopathy]. Z Kardiol (1998) 0.86
Immunohistochemistry in dilated cardiomyopathy. Eur Heart J (1995) 0.85
[Emergency heart valve replacement after acute cerebral embolism during florid endocarditis]. Med Klin (Munich) (1998) 0.84
Upregulation of bradykinin B1-receptor expression after myocardial infarction. Br J Pharmacol (2000) 0.84
Antimyosin scintigraphy and immunohistologic analysis of endomyocardial biopsy in patients with clinically suspected myocarditis--evidence of myocardial cell damage and inflammation in the absence of histologic signs of myocarditis. J Am Coll Cardiol (1998) 0.84
The shift in the myocardial adenine nucleotide translocator isoform expression pattern is associated with an enteroviral infection in the absence of an active T-cell dependent immune response in human inflammatory heart disease. J Am Coll Cardiol (2000) 0.84
Inhibition of the adenine nucleotide translocator by organ specific autoantibodies in primary biliary cirrhosis. Clin Exp Immunol (1984) 0.84
Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure. Circ Res (1994) 0.83
Methylprednisolone in chronic myocarditis. Postgrad Med J (1994) 0.83
[Acute myocardial infarct caused by a muscle bridge of the anterior interventricular ramus: complicated course with vascular perforation after stent implantation]. Z Kardiol (1997) 0.83
The role of the ADP/ATP carrier in the pathogenesis of viral heart disease. Eur Heart J (1995) 0.83
Adenine nucleotide translocator in dilated cardiomyopathy: pathophysiological alterations in expression and function. Mol Cell Biochem (1997) 0.83
Immunoelectrophoretic characterization of the ADP/ATP carrier from heart, kidney, and liver. Arch Biochem Biophys (1985) 0.83
[Magnetcardiographic detection of abnormal intraventricular activation in patients with ischemic heart disease with and without tachycardia]. Herzschrittmacherther Elektrophysiol (1997) 0.82
Roles of T cells in coxsackievirus B-induced disease. Curr Top Microbiol Immunol (1997) 0.82
[Diabetic cardiopathy: pathogenesis, diagnosis and therapy]. Internist (Berl) (2003) 0.81
Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses. Basic Res Cardiol (2014) 0.81
The myocardial expression of the adenine nucleotide translocator isoforms is specifically altered in dilated cardiomyopathy. Herz (2000) 0.80
Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. Am J Physiol (1988) 0.80
Transfer of human myocarditis into severe combined immunodeficiency mice. Circ Res (1994) 0.80
The possible value of synthetic peptides in the diagnosis and therapy of myocarditis and dilated cardiomyopathy. Eur Heart J (1991) 0.80
Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial. Eur J Cancer (2004) 0.80
Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Mol Med (Berl) (2005) 0.80
Late potentials and heart rate variability in heart muscle disease. Eur Heart J (1994) 0.79
Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial. Int J Cardiol (2012) 0.79
Platelet activation in diabetic microangiopathy. Platelets (1998) 0.79
Vasopressin mRNA in the neurolobe of the rat pituitary. Neurosci Lett (1990) 0.79
Chronic inflammation in the myocardium of patients with clinically suspected dilated cardiomyopathy. J Card Fail (1994) 0.79
High molecular weight adiponectin correlates positively with myeloperoxidase in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2008) 0.79
Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion. Am J Cardiol (1999) 0.79
[Diagnostic approach and optimal treatment of aortic valve stenosis]. Herz (1998) 0.79
Impairment of myocardial calcium homeostasis by antibodies against the adenine nucleotide translocator. Cell Calcium (1999) 0.78
Is myocardial Na+/Ca2+ exchanger transcription a marker for different stages of myocardial dysfunction? Quantitative polymerase chain reaction of the messenger RNA in endomyocardial biopsies of patients with heart failure. J Am Coll Cardiol (2000) 0.78
[Myocarditis and dilated cardiomyopathy. New methods in diagnosis and therapy]. MMW Fortschr Med (2002) 0.78
Cell-mediated cytotoxicity in hearts with dilated cardiomyopathy: correlation with interstitial fibrosis and foci of activated T lymphocytes. J Am Coll Cardiol (1997) 0.78
[Surgical angioplasty of the left main coronary artery. Evaluation and postoperative follow-up with intravascular ultrasound]. Z Kardiol (2002) 0.78
Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury. J Mol Med (Berl) (2006) 0.78
[Antimyosin scintigraphy for diagnosis and follow-up of patients with clinically suspected myocarditis]. Z Kardiol (1998) 0.78
[Optimal management of primary and secondary mitral regurgitation]. Herz (1998) 0.77
[Acute coronary artery occlusion after elective percutaneous transluminal coronary angioplasty. Incidence and therapy in 5000 consecutive patients]. Dtsch Med Wochenschr (1994) 0.77
[PTCA in the acute state of myocardial infarct: hospital course of 785 consecutive patients]. Z Kardiol (1994) 0.77
Enzymatic analysis and collagen content in endomyocardial biopsy samples of patients with congestive cardiomyopathy of unknown etiology. Clin Cardiol (1980) 0.77